Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 284,000 | 267,000 | 276,000 | 154,000 | 595,000 |
| Receivables | 1,316,000 | 1,246,000 | 1,237,000 | 1,334,000 | 1,336,000 |
| Inventories | 889,000 | 931,000 | 972,000 | 927,000 | 899,000 |
| Income taxes - deferred | 404,000 | 458,000 | 409,000 | 417,000 | 405,000 |
| Other current assets | 0 | 0 | 5,000 | 7,000 | 7,000 |
| TOTAL | $3,091,000 | $3,105,000 | $3,213,000 | $3,149,000 | $3,569,000 |
| Non-Current Assets | |||||
| PPE Net | 1,669,000 | 1,670,000 | 1,684,000 | 1,702,000 | 1,708,000 |
| Intangibles | 16,144,000 | 16,234,000 | 16,333,000 | 16,442,000 | 16,554,000 |
| Other Non-Current Assets | 281,000 | 281,000 | 272,000 | 266,000 | 239,000 |
| TOTAL | $18,094,000 | $18,185,000 | $18,289,000 | $18,410,000 | $18,501,000 |
| Total Assets | $21,185,000 | $21,290,000 | $21,502,000 | $21,559,000 | $22,070,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,000 | 4,000 | 4,000 | N/A | 254,000 |
| Accounts payable and accrued liabilities | 288,000 | 203,000 | 256,000 | 223,000 | 217,000 |
| Accrued Expenses | 1,180,000 | 1,327,000 | 1,296,000 | 1,329,000 | 1,300,000 |
| Other current liabilities | 197,000 | 273,000 | 331,000 | 336,000 | 269,000 |
| TOTAL | $1,669,000 | $1,807,000 | $1,887,000 | $1,892,000 | $2,040,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,255,000 | 4,257,000 | 4,259,000 | 4,197,000 | 4,670,000 |
| Other Non-Current Liabilities | 1,988,000 | 2,008,000 | 1,981,000 | 2,014,000 | 2,003,000 |
| TOTAL | $8,120,000 | $8,130,000 | $8,094,000 | $8,127,000 | $8,661,000 |
| Total Liabilities | $9,789,000 | $9,937,000 | $9,981,000 | $10,019,000 | $10,701,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,429,295 | 1,451,346 | 1,481,506 | 1,530,671 | 1,528,206 |
| Common Shares | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 |
| Retained earnings | -4,268,000 | -4,381,000 | -4,488,000 | -4,630,000 | -4,776,000 |
| Other shareholders' equity | -79,000 | -138,000 | -132,000 | -123,000 | -119,000 |
| TOTAL | $11,396,000 | $11,353,000 | $11,521,000 | $11,540,000 | $11,369,000 |
| Total Liabilities And Equity | $21,185,000 | $21,290,000 | $21,502,000 | $21,559,000 | $22,070,000 |